methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol]
- RxCUI
- 1358619
- RxNorm name
- methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol]
- Display name
- DEPO-Medrol (Injectable)
- Full name
- methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol]
- Term type
- SBD
- Status
- Active
- Strength
- 80 mg/ml
- Dose form
- Susp
- Route
- Injectable
- Updated
- 2026-10-15 15:43:21
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122012
- Active start
- 122012
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| methylprednisolone acetate | 80 MG / 1 ML | methylprednisolone | methylprednisolone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Suspension | 316950 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| methylprednisolone | 6902 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | DEPO-Medrol 80 MG/ML Injectable Suspension | 1 | NAMES |
| RxNorm Name | methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] | 1 | NAMES |
| RxNorm Synonym | Depo-Medrol 80 MG/ML Injectable Suspension | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1358619 | 1 | CODES |
| MMSL_CODE | MTH_RXN_BD2314 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0009-0306-02 | 0009-0306 | Depo-Medrol methylprednisolone acetate | Pharmacia & Upjohn Company LLC | NDA011757 |
| 0009-0306-12 | 0009-0306 | Depo-Medrol methylprednisolone acetate | Pharmacia & Upjohn Company LLC | NDA011757 |
| 50090-1823-0 | 50090-1823 | DEPO-MEDROL methylprednisolone acetate | A-S Medication Solutions | NDA011757 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 823b0010-2b57-4e76-b5ac-4a8c2963438f | 2026-01-21 | Warnings, Adverse reactions | 0009-0306-02 0009-0306-12 0009-0306 00009030612 00009030602 1358619 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 9a7b3837-e038-48bf-97e9-78ad463760dc | 2026-01-21 | Warnings, Adverse reactions | 00009347501 00009347503 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | bf1b104d-85cb-414d-a366-78068c82c883 | 2025-12-01 | Warnings, Adverse reactions | 00009347522 00009347523 |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | e8209047-c1e6-4081-a6d3-c603d9ee4f14 | 2025-10-27 | Warnings, Adverse reactions | 50090-1823-0 50090-1823 50090182300 1358619 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-Medrol 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] [SBD] · Depo-Medrol 80 MG/ML Injectable Suspension [SY] | 3 | 22 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| e8209047-c1e6-4081-a6d3-c603d9ee4f14 | DEPO-Medrol 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] [SBD] · Depo-Medrol 80 MG/ML Injectable Suspension [SY] | 3 | 14 | DEPO-MEDROL | 20251027 |
| c5ca262e-5558-4065-8ef5-e2e76f3635e5 | DEPO-Medrol 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] [SBD] · Depo-Medrol 80 MG/ML Injectable Suspension [SY] | 3 | 1 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | 20120201 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20260121 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20260121 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251217 |
| bf1b104d-85cb-414d-a366-78068c82c883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251201 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20251114 |
| e8209047-c1e6-4081-a6d3-c603d9ee4f14 | DEPO-MEDROL | A-S Medication Solutions | 20251027 |
| bf1b104d-85cb-414d-a366-78068c82c883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251008 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251006 |
| bf1b104d-85cb-414d-a366-78068c82c883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20250828 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20250818 |
| 69ca1281-55b7-426d-92e7-318414d7f226 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | REMEDYREPACK INC. | 20200406 |
| 43775cf1-4477-449a-e054-00144ff88e88 | ReadySharp Anesthetics + Methylprednisolone 80 | Terrain Pharmaceuticals | 20161209 |
| cb33bed8-6f99-4a00-aa3a-c74e4f0a17e7 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia and Upjohn Company LLC | 20140124 |
| 95186b1b-cb0f-4091-86fe-c57d1d1e4986 | National Council for Prescription Drug Programs | 20120724 | |
| 11505f08-dcaf-40aa-99cb-2d5714d90aef | National Council for Prescription Drug Programs | 20120724 | |
| b0d29b11-5614-4fb2-b45f-d19957d89fd7 | National Council for Prescription Drug Programs | 20120724 | |
| b9dc41a9-eb11-4db5-b0c1-2b0ec14cee04 | National Council for Prescription Drug Programs | 20120724 | |
| 59d7e0c4-5d87-46ca-bbc9-351657b25dd5 | National Council for Prescription Drug Programs | 20120724 | |
| 480595b6-0359-41f2-899f-4084cd256b20 | National Council for Prescription Drug Programs | 20120724 | |
| c5471b1d-6144-4774-ac4a-da96ba7e8495 | National Council for Prescription Drug Programs | 20120724 | |
| c5cab2df-bbc5-43e5-93e1-f4611d6eb481 | National Council for Prescription Drug Programs | 20120724 | |
| c5ca262e-5558-4065-8ef5-e2e76f3635e5 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | Dispensing Solutions, Inc. | PSS World Medical, Inc. | 20120201 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | methylprednisolone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | methylprednisolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | methylprednisolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | methylprednisolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | D008775 | Methylprednisolone | CHEM | has_ingredient | methylprednisolone |
| MEDRT | D000077555 | Methylprednisolone Acetate | CHEM | has_ingredient | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 80 MG/ML (expressed as methylprednisolone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA011757 |
| NAMES | Prescribable Synonym | DEPO-Medrol 80 MG/ML Injectable Suspension |
| NAMES | Tallman Synonym | DEPO-Medrol 80 MG/ML Injectable Suspension |
| NAMES | Tallman Synonym | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [DEPO-Medrol] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |